Hormone control breakthrough from Ergopharm
Ergopharm proudly introduces 11-OXO™, the first selective inhibitor of 11b-hydroxysteroid dehydrogenase type I reductase. Finally, cortisol control that delivers on the promises.
Ergopharm has found the key to obtaining:
* Decreased body fat (especially visceral adipose tissue)
* Increased muscle density (hardness)
* Enhanced insulin sensitivity and glycogen deposition
* Increased strength
* Improved brain and CNS function